目录
- Neuroprotective and neuroregenerative potential of pharmacologically-induced hypothermia with D-alanine D-leucine enkephalin in brain injury
- Roles and functions of Atp6ap2 in the brain
- Magnesium sulfate and fetal neuroprotection:overview of clinical evidence
- Animal models of amyotrophic lateral sclerosis:a comparison of model validity
- Polyphenols-gut microbiota interplay and brain neuromodulation
- Ketogenic diet versus ketoacidosis: what determines the influence of ketone bodies on neurons?
- Apomorphine effects on the hippocampus
- MicroRNAs of microglia: wrestling with central nervous system disease
- Inhibiting the kynurenine pathway in spinal cord injury: multiple therapeutic potentials?
- Is ATP a key player in conditioning neurons to support axonal regeneration?
- Role of chondroitin sulfate proteoglycan signaling in regulating neuroinflammation following spinal cord injury
- Do new neurons contribute to functional reorganization after brain damage?
- Emerging roles of the neural adaptor FE65 in neurite outgrowth
- Role and limitations of rehabilitationinduced neural network remodeling after stroke
- Sarcopenia diagnosed using masseter muscle area predictive of early mortality following severe traumatic brain injury
- Novel translational rat models of dopamine transporter deficiency
- The rat model of placental ischemia as a model of postpartum posterior cortical atrophy?
- New models to study vulvodynia:hyperinnervation and nociceptor sensitization in the female genital tract
- Consequences of redefining Alzheimer’s disease in terms of amyloid burden without regard to cognitive decline
- Putative roles of cathepsin B in Alzheimer’s disease pathology: the good, the bad, and the ugly in one?
- Nose-to-brain drug delivery approach:a key to easily accessing the brain for the treatment of Alzheimer’s disease
- Cell-based therapy in Alzheimer’s disease: can human fetal cholinergic neurons “untangle the skein”?
- Peptide aptamer-mediated modulation of prion protein α-cleavage as treatment strategy for prion and other neurodegenerative diseases
- 2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain
- Rosmarinic acid elicits neuroprotection in ischemic stroke via Nrf2 and heme oxygenase 1 signaling
- Neuroprotective effect of baicalin on focal cerebral ischemia in rats
- Dynamic changes in growth factor levels over a 7-day period predict the functional outcomes of traumatic brain injury
- Prevalence of white matter hyperintensities increases with age
- Downregulation of signal transduction and STAT3 expression exacerbates oxidative stress mediated by NLRP3 inflammasome
- Dysphagia in patients with isolated pontine infarction
- Epigenetic marks are modulated by gender and time of the day in the hippocampi of adolescent rats:a preliminary study
- Partial improvement in performance of patients with severe Alzheimer’s disease at an early stage of fornix deep brain stimulation
- Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer’s disease
- Analysis of transcriptome sequencing of sciatic nerves in Sprague-Dawley rats of different ages
- Lithium promotes recovery of neurological function after spinal cord injury by inducing autophagy
- Huangqinflavonoid extraction for spinal cord injury in a rat model